Medulloblastoma

This is a type of brain tumor that most often occurs in children. It starts in the cerebellum, which is part of the brain that controls balance and coordination. It's a serious type of cancer.

Condition

What people with Medulloblastoma report

Every report comes from a Lived member, sent anonymously.

Have you had Craniospinal Irradiation for Medulloblastoma?

NameHow it went

About Medulloblastoma

What It Is

Medulloblastoma is a fast-growing cancerous brain tumor that starts in the cerebellum, the part of the brain at the lower back of the skull that controls balance, coordination and posture. It is the most common malignant brain tumor in children, most often diagnosed before age 10, but about 3 in 10 cases occur in adults, most often between ages 20 and 40. All medulloblastomas are classed as grade 4, meaning they grow quickly, and they can spread through the cerebrospinal fluid (the fluid that bathes the brain and spinal cord) to other parts of the brain and spine. Many of the first symptoms come from the tumor blocking the flow of that fluid. The fluid builds up and raises pressure inside the skull, a problem called hydrocephalus. This typically causes headaches that are worst on waking, nausea and vomiting, and unusual tiredness. Pressure on the cerebellum causes unsteady walking, clumsiness and sometimes double vision. Infants may instead be irritable, feed poorly, miss developmental milestones or have a growing head size. In children, symptoms usually build over two to three months before diagnosis.

Causes & Risk Factors

Medulloblastoma develops from immature cells left over from fetal development that begin to grow and divide abnormally. In most people, no cause is found, and nothing a parent or patient did is known to bring it on. A small share of cases are linked to inherited conditions that raise the risk, including Gorlin syndrome (nevoid basal cell carcinoma syndrome), Li-Fraumeni syndrome, Turcot syndrome and Rubinstein-Taybi syndrome. Because an inherited cause is not always obvious from family history, genetic counseling and testing are often offered after diagnosis. The results can affect the person's own treatment and cancer screening and may matter for siblings and other relatives.

How It's Diagnosed

Diagnosis usually starts with a neurological exam and brain imaging. An MRI (magnetic resonance imaging) scan with contrast dye shows the tumor, typically as a mass in the cerebellum, and whether fluid has built up. An MRI of the whole spine is also done, along with a lumbar puncture (spinal tap) to look for tumor cells in the spinal fluid, because finding spread changes the treatment plan. The diagnosis is confirmed by examining tumor tissue removed during surgery. Beyond the microscope, laboratories now test the tumor's genetic features, which sort medulloblastoma into four main molecular groups. Two are named for the growth-signaling pathway that drives them, WNT and SHH (sonic hedgehog); the other two are simply called group 3 and group 4. These groups behave differently. For example, WNT tumors in children usually have a very good outlook, while group 3 tumors with extra copies of MYC, a gene that drives cell growth, are harder to treat. Doctors combine these results with age, how much tumor remains after surgery and whether it has spread to assign a risk group. For children older than 3, a tumor is generally called average risk if it was fully or almost fully removed and has not spread, and high risk if tumor remains or it has spread. The risk group guides how intensive treatment needs to be.

Treatment Options

Treatment is usually planned by a specialized team that includes a neurosurgeon, a radiation oncologist and a pediatric or neuro-oncologist. Because the disease is rare, being treated at a center experienced with brain tumors, and considering a clinical trial, can matter. Surgery comes first. The goal is to remove as much tumor as can be taken out safely, both to confirm the diagnosis and because less remaining tumor is linked to better outcomes. If fluid has built up, surgeons may also need to relieve the pressure, sometimes with a shunt, a thin tube placed under the skin that drains excess fluid to the abdomen or chest. For older children and adults, surgery is usually followed by radiation to the entire brain and spinal cord (craniospinal radiation), because tumor cells can travel through the spinal fluid, with an extra dose to the tumor site. High-risk tumors receive a higher radiation dose. Proton therapy, a form of radiation that limits dose to tissue beyond the target, is often used. Chemotherapy, typically combinations that include cisplatin, vincristine and either lomustine or cyclophosphamide, is given during and after radiation. For children with average-risk tumors, this combination keeps the cancer from returning for at least five years in roughly 70% to 85% of cases. For high-risk disease, about half to two thirds achieve long-term control. In children 3 and younger, radiation can seriously harm the developing brain, so chemotherapy, sometimes at high doses with a stem cell rescue to restore blood cells, is used to delay, reduce or avoid it. Some young children with certain SHH tumors do very well this way. When the cancer comes back, options include more surgery, further radiation or chemotherapy, and for some SHH tumors a targeted drug called vismodegib, used in people who have finished growing.

What to Expect

Treatment is demanding, combining several therapies over many months, and outlook varies widely with age, molecular group, risk group and how the tumor responds. Many children are cured, while others face a tumor that returns, most often within the first three years. Recovery from surgery can be difficult. About a quarter of children develop cerebellar mutism syndrome (also called posterior fossa syndrome) within a day or two of surgery, losing speech and having trouble with swallowing, balance, muscle tone and mood. Symptoms can ease with time, but about half of those affected have lasting neurological or thinking problems. Physical, speech and occupational therapy are often part of recovery. Some people also have persistent hydrocephalus after surgery and need a long-term shunt, which can occasionally block or become infected and need repair. Survivors often live with late effects of treatment that appear months or years later. These can include hearing loss (especially from cisplatin), slowed growth, hormone and thyroid problems, heart effects, and changes in attention, learning, and memory, which tend to be greater in younger children and with higher radiation doses. There is also a raised risk of second tumors. Regular MRI scans continue for years to check for recurrence, and lifelong survivorship care, including hearing tests, hormone checks, thinking and learning assessments, and school or work support, helps catch and manage these problems.

When to Seek Help

See a doctor if a child or adult has headaches that are worse in the morning or ease after vomiting, repeated vomiting without another explanation, or new clumsiness, unsteady walking, double vision or slowed speech that persists or gets worse. In infants, a rapidly enlarging head, poor feeding or loss of milestones also needs evaluation. For someone who has a shunt or is being treated, contact the neurosurgery or cancer team right away for a returning headache, vomiting, light sensitivity, unusual sleepiness, or redness, swelling or tenderness along the shunt, since these can mean the shunt has stopped working or is infected. Call 911 if the person has a seizure, becomes very hard to wake or loses consciousness.

Questions to Ask Your Doctor

  1. 1.What molecular group and risk group is this tumor, and how do they change the treatment plan and outlook?
  2. 2.How much tumor was removed, and has it spread to the spine or spinal fluid?
  3. 3.What are the realistic benefits and long-term effects of radiation at this age, and is a clinical trial an option?
  4. 4.Should we have genetic counseling or testing, and what would the results mean for the family?
  5. 5.What survivorship follow-up will be needed for hearing, hormones, growth, learning and recurrence, and who coordinates it?

Last reviewed • Oct 2026

Educational content, not medical advice.